Dietary Supplement packaged in the following configurations: (1) KIRKMAN, Enzym-Complete /…
Recalling firm: National Enzyme Co
Firm is recalling dietary supplements containing a raw material which may contain >0.3 ppb chloramphenicol
Historical recall record. This is not a new recall announcement. “Terminated” describes the FDA recall process; it does not certify that an individual package is safe. FDA termination date: Mar 3, 2015.
Check your package
Compare the exact product and package details with the label you have.
FDA code information
Lot #'s: 52587047, 52587048, 52587049, 52587050, 52588047, 52588048, 52588049, 52588050, 52588051, 53853006, 53853007, 53853008, 53853009, 53853010, and 54956000
Match the product, package size, and code together. A missing match does not guarantee safety.
Full FDA record and distribution details
Original product description
Dietary Supplement packaged in the following configurations: (1) KIRKMAN, Enzym-Complete / DPP-IV, Broad Spectrum Digestion Formula with Dipeptidyl Peptidase IV Analog, packaged in 60-capsule bottles (SKU 52587), 120-capsule bottles (SKU 52588), and 200-capsule bottles (SKU 53853). Manufactured exclusively for KIRKMAN, Lake Oswego, OR; (2) KIRKMAN, EnZym-Complete / DPP-IV, GF/CF Enzyme Dietary Supplement, packaged in 200-capsule bottles (SKU 54956). Manufactured exclusively for KIRKMAN, Lake Oswego, OR;
Original FDA recall reason
Firm is recalling dietary supplements containing a raw material which may contain >0.3 ppb chloramphenicol
Recall details
- Recall number
- F-0747-2014
- Event ID
- 66658
- FDA status
- Terminated
- Initiated
- Oct 30, 2013
- Reported
- Dec 25, 2013
- Classified
- Dec 13, 2013
- Terminated
- Mar 3, 2015
- Quantity
- 16733 bottles
- Location
- Forsyth, MO, United States
- Initiation type
- Voluntary: Firm initiated
- Notification
- Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Where it was distributed
Domestic distribution of the product is nationwide with direct accounts in 27 states in all geographical regions. Foreign distribution consists of direct accounts in the following countries: Canada, China, Malaysia, Norway, Slovakia, South Korea, Sweden, Taiwan, and the United Kingdom.
Data updated September 16, 2026. View official FDA data ↗
Follow official FDA and manufacturer guidance.